Permeon Biologics, Inc

INTRAPHILIN

biotechnology and pharmaceutical products, namely, therapeutic proteins for human use; diagnostic and prognostic preparations for medical and veterinary purposes;biological and chemical reagents and preparations, all for use in industrial, biological and medical research; chemical materials used in analytical chemistry and biochemistry for the isolation, purification or separation of chemical, biochemical and biotechnological products for industrial and commercial use; kits comprising chemical, biochemical and biotechnological products and preparations and agents, all for scientific and industrial purposes;scientific research and development related to protein properties or nucleic acid properties; research and development of diagnostics for medical and clinical use; research and development in the field of pharmaceuticals;

PERMEON BIOLOGICS

medicinal preparations, namely, polypeptides, nucleic acids, and complexes for pharmaceutical and clinical use for the alteration of cell physiology by modulation of DNA, transcription, RNA, translation, or post-translational processes, all for use in the delivery of agonists, antagonists, and replacement proteins to treat diseases in the fields of cardiovascular disease, oncology, auto-immunity, inflammatory disease, infectious disease, neurology and diseases of the central nervous system, in born errors of metabolism, lipid storage diseases, musculoskeletal diseases, diseases of the eye;biological preparations for medical laboratory use, namely, polypeptides, nucleic acids, and complexes for the alteration of cell physiology by modulation of DNA,transcription, RNA, translation, or post-translational processes;BIOLOGICS;